Prestigious European award for Adam Antebi

© Max Planck Institute for Biology of Ageing
Max Planck director Adam Antebi receives the prestigious Advanced Grant by the European Research Council.

For a period of five years, Adam Antebi, a Director at the Max Planck Institute for Biology of Ageing in Cologne, will receive the Advanced Grant of the European Research Council (ERC). In a highly selective process, this award is given only to world leading researchers carrying out groundbreaking work and is therefore considered a great scientific distinction.

The European Research Council promotes basic research by awarding grants to outstanding scientists. With the ERC Advanced Grant, Adam Antebi's highly innovative research is funded with 2.5 million euros for a period of five years.

In his project "NuAge", Antebi seeks to investigate how a tiny organelle inside the nucleus of the cell, called the nucleolus, influences the ageing process.
"We’re very excited about this grant because we are examining how the nucleolus impacts longevity and immunity in different model organisms, including the small roundworm Caenorhabditis elegans and the turquoise killifish Nothobranchius furzeri” explains Antebi.
In addition, the scientists want to investigate whether nucleolar markers are associated with human health and whether different longevity pathways converge on the nucleolus to affect health and life span.
 
This will be the sixth time a director at the Max Planck Institute for Biology of Ageing has received this distinguished European award, which can further advance the mission of the institute to understand the ageing process and improve health into old age.

This website uses Cookies. By continuing to navigate on this website without changing the Cookie settings of your internet browser you agree to our use of Cookies. Privacy Policy